Key result
Russian adults show substantially higher cardiac biomarkers than Norwegians despite comparable lipid profiles.
Why the study?
Cardiovascular disease mortality rates at ages 35-69 years in Russia are eight times higher than in neighbouring Norway. Comparing blood-based biomarker profiles between these two populations was needed to help identify reasons for this substantial difference in risk.
Do differences in blood-based cardiovascular biomarkers (lipids, NT-proBNP, hs-cTnT, and hsCRP) between general population cohorts in Russia and Norway explain Russia's substantially higher cardiovascular mortality rate?
Cross-Sectional (n=21,692)
Yes
Do differences in blood-based cardiovascular biomarkers (lipids, NT-proBNP, hs-cTnT, and hsCRP) between general population cohorts in Russia and Norway explain Russia's substantially higher cardiovascular mortality rate?
Because blood lipid levels are comparable between Russia and Norway while NT-proBNP and hs-cTnT are markedly elevated in Russia independently of classic risk factors and prior coronary heart disease, non-ischaemic pathways to cardiac damage likely play a major role in Russia's high cardiovascular mortality.
Answers are grounded in this paper and cite their sources.
Similar lipids but higher NT-proBNP and hs-cTnT in Russia implicate non-ischaemic pathways in excess mortality; leaves open causal mechanisms and prevention targets.
BACKGROUND: Russia has one of the highest rates of mortality from cardiovascular disease (CVD). At age 35-69 years, they are eight times higher than in neighbouring Norway. Comparing profiles of blood-based CVD biomarkers between these two populations can help identify reasons for this substantial difference in risk. METHODS: We compared age-standardised mean levels of CVD biomarkers for men and women aged 40-69 years measured in two cross-sectional population-based studies: Know Your Heart (KYH) (Russia, 2015-2018; n=4046) and the seventh wave of the Tromsø Study (Tromsø 7) (Norway, 2015-2018; n=17 646). A laboratory calibration study was performed to account for inter-laboratory differences. RESULTS: Levels of total, low-density lipoprotein-, high-density lipoprotein-cholesterol and triglycerides were comparable in KYH and Tromsø 7 studies. N-terminal pro-b-type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T (hs-cTnT) and high-sensitivity C-reactive protein (hsCRP) were higher in KYH compared with Tromsø 7 (NT-proBNP was higher by 54.1% (95% CI 41.5% to 67.8%) in men and by 30.8% (95% CI 22.9% to 39.2%) in women; hs-cTnT-by 42.4% (95% CI 36.1% to 49.0%) in men and by 68.1% (95% CI 62.4% to 73.9%) in women; hsCRP-by 33.3% (95% CI 26.1% to 40.8%) in men and by 35.6% (95% CI 29.0% to 42.6%) in women). Exclusion of participants with pre-existing coronary heart disease (279 men and 282 women) had no substantive effect. CONCLUSIONS: Differences in cholesterol fractions cannot explain the difference in CVD mortality rate between Russia and Norway. A non-ischemic pathway to the cardiac damage reflected by raised NT-proBNP and hs-cTnT is likely to contribute to high CVD mortality in Russia.
No takes yet. Share an insight, caveat, or question.
lakunchykova et al. (2020) conducted a cross-sectional in Cardiovascular disease risk in the general population (n=21,692). Russian population residence (Know Your Heart cohort) vs. Norwegian population residence (Tromsø 7 cohort) was evaluated on Age-standardised mean levels and percentage differences of blood-based cardiovascular biomarkers (NT-proBNP, hs-cTnT, hsCRP, and lipid profile) (54.1% higher NT-proBNP in men (30.8% in women); 42.4% higher hs-cTnT in men (68.1% in women), 95% CI 41.5% to 67.8%, p=<0.001). Russian adults in the Know Your Heart study had comparable lipid profiles to Norwegians but higher NT-proBNP and hs-cTnT.
Synapse has enriched 10 related papers. Consider them for comparative context: